Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 1997

View Archived Issues

FDA wants stronger warning labels for fen/phen

Review of fenfluramines points to neurotoxicity

Disappointing phase III trial results with interferon gamma for atopic dermatitis

Faulding's generic acyclovir receives FDA approval

Mayo Clinic, Wyeth-Ayerst plan fen/phen study

DIAMOND CHF study results reported

FDA approves Gensia's injectable acyclovir

Seven studies published on Emdogain

SYST-EUR trial results presented

Panretin trial in KS halted early

Notice of allowance for LHRH vaccine patent

FKBP12 inhibitors in the pipeline at Guilford

Innothera discloses more agents for venous function deficiency

P&U cephem derivatives for inhibiting HLE

Stromelysin inhibitors: New approach to treating arthritis?

Kos Pharmaceuticals: Q4 and year-end highlights

Cortecs granted patent for Flustat

Novopharm Biotech, Genesys Pharma receive approval to amalgamate

Pharos receives patent for novel method of controlling and treating inflammation

Inex: Q2 1997 highlights

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...